Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)

Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)

Treatment for Hodgkin lymphoma (HL) in adults comprises substantial risk of chemotherapy‐induced peripheral neurotoxicity. Here, we describe the case of patient with Charcot–Marie–Tooth disease or HSMN1 and advanced Hodgkin lymphoma undergoing treatment with modified BEACOPP achieving complete remis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical case reports 2022-05, Vol.10 (5), p.e05766-n/a
Hauptverfasser: Hess, Patrick P., Ventura Ferreira, Monica S., Rolles, Benjamin, Kirschner, Martin, Holtbernd, Florian, Tometten, Mareike, Brümmendorf, Tim H., Beier, Fabian
Format: Artikel
Sprache:eng
Schlagworte:
Case Report
Case Reports
Chemotherapy
Disease
Genes
hematology
Hodgkin
Leukemia
Lymphatic system
Lymphoma
Medical imaging
Mutation
neurology
neuropathy
Neurotoxicity
Patients
Proteins
Remission (Medicine)
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Treatment for Hodgkin lymphoma (HL) in adults comprises substantial risk of chemotherapy‐induced peripheral neurotoxicity. Here, we describe the case of patient with Charcot–Marie–Tooth disease or HSMN1 and advanced Hodgkin lymphoma undergoing treatment with modified BEACOPP achieving complete remission without major aggravation of neurological symptoms. Patients with Charcot–Marie–Tooth disease or HSMN1 and advanced Hodgkin lymphoma can be successfully treated with modified BEACOPP achieving complete remission without major aggravation of neurological symptoms.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.5766